CUSIP 74168J101COMPRMEQ4 2025
18 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Alphabet Inc. | 16.56M | $57.47M |
| 2 | Blackrock, Inc. | 8.27M | $28.69M |
| 3 | Vanguard Group Inc | 6.47M | $22.44M |
| 4 | Ark Investment Management LLC | 5.37M | $18.63M |
| 5 | State Street Corp | 5.10M | $17.68M |
| 6 | Sumitomo Mitsui Trust Group, Inc. | 3.25M | $11.26M |
| 7 | Amova Asset Management Americas, Inc. | 3.25M | $11.20M |
| 8 | Casdin Capital, LLC | 3.17M | $10.99M |
| 9 |
| 4 | Nov 5, 2025 | Fmr LLC | 13G/A | 3.8% | 6.73M | SEC |
| 5 | Aug 11, 2025 | Arch Venture Fund X, L.P. | 13D/A | 10.4% | — | SEC |
| 6 | Feb 14, 2025 | Newpath Partners, L.P. | 13G/A | 4.7% | 6.11M | SEC |
| 7 | Nov 22, 2024 | Arch Venture Fund Xii, L.P. | 13D/A | 11.8% | 15.46M | SEC |
| 8 | Nov 12, 2024 | Fmr LLC | 13G/A | 6.4% | — | SEC |
| 9 | Oct 4, 2024 | Bristol Myers Squibb Co | 13G | 8.4% | 11.01M | SEC |
| 10 | Feb 29, 2024 | Gv 2019, L.P. | 13G/A | 8.2% | 10.10M | SEC |
See the full Schedule 13D/13G history for Prime Medicine Inc.
Unlock full history| Balyasny Asset Management L.P. |
| 3.12M |
| $10.84M |
| 10 | Woodline Partners LP | 3.00M | $10.42M |